glp 1 afib GLP-1 drugs outperform SGLT-2 drugs for patients with and type 2 diabetes Effects of Glucagon-Like Peptide-1 Receptor
Description
Cooper MA, Colonna M, Yokoyama WM
The Current GLP-1 Landscape GLP-1 (glucagon-like peptide-1) receptor agonists were initially developed to help manage type 2 diabetes by improving insulin sensitivity and reducing blood glucose levels
These experiences could inform RECOVERs approaches to the planned trials
The semaglutide known as Ozempic is intended to be used for people with diabetes
www.fda.gov/Drugs/DrugSafety/ 18
Tirzepatide: GI side effects common but well-characterized
